Advancing antimalarial drug research through open source initiatives

24 Jul 2013

The Guardian: MMV's Head of Discovery, Jeremy Burrows explains how open research can lead to new drugs tackling diseases that afflict the world's poor.

Conventional drug discovery is typically clothed in secrecy, as scientists compete to find the next billion-dollar blockbuster. For "diseases of poverty" such as malaria, however, the low commercial value of the end-product means that the need for secrecy and competition is diminished, if not counterproductive. Scientists across the world are now starting to conduct research on the diseases that affect the world's poorest more openly, and to great effect....

Read the full article on The Guardian website.